The Massive Racial Blind Spot in Cancer-Drug Studies

The Massive Racial Blind Spot in Cancer-Drug Studies

To ensure that a new drug works, and is safe, it must be tested through a clinical trial. Before it can be sold on the market, people with a certain disease are given the drug, and compared to others who receive a placebo. If the people who got the medication do better, the drug is […]

Breakthrough for AstraZeneca as it proves key cancer drug Imfinzi improves life expectancy

Breakthrough for AstraZeneca as it proves key cancer drug Imfinzi improves life expectancy

Pharmaceutical company AstraZeneca has achieved a major breakthrough after revealing that one of the most important drugs in its cancer portfolio, Imfinzi, drastically improves patient survival rates. The data was unveiled at the World Conference on Lung Cancer and showed Imfinzi reduced the risk of death in patients with stage-three lung cancer by a third. Imfinzi belongs to a […]

Roche Escapes Stock-Drop Suit Over Cancer Drug Results

Roche Escapes Stock-Drop Suit Over Cancer Drug Results

By Bill Wichert Law360 (September 25, 2018, 3:27 PM EDT) — Roche Holding AG has knocked down a putative securities class action after a New Jersey federal judge concluded that the pharmaceutical giant and its executives did not make false or misleading… To view the full article, register now. Source link

Cancer Drug Therapy Market 2018-2023 with Strategic Trends Growth, Revenue

Cancer Drug Therapy Market 2018-2023 with Strategic Trends Growth, Revenue

The research report on the Global Cancer Drug Therapy Market delivers extensive analysis of market trends and shares. The report analyzes the current market size, recent market trends, key segments and future prospects of the global Cancer Drug Therapy market (2018-2025). The market shares of segments (players, type, application and regions) are prepared to give […]

Lung cancer drug could be repurposed to target 'zombie' proteins linked to leukemia

Lung cancer drug could be repurposed to target 'zombie' proteins linked to leukemia

A new study by scientists at the University of Liverpool highlights how a clinically-approved lung cancer drug could potentially be ‘repurposed’ to design new treatments for future cancer therapies. The research, published in Science Signaling, focuses on a protein called TRIB2, which is linked to promoting survival and drug resistance in solid tumours and blood […]

AstraZeneca reports promising results from late-stage trial for cancer drug

AstraZeneca reports promising results from late-stage trial for cancer drug

AstraZeneca photo AstraZeneca and MedImmune, its global biologics research and development arm, presented data indicating that lung cancer drug Imfinzicould lengthen the lives of people with a type of stage 3 lung cancer. Sean Bohen, Executive vice president, global medicines development and chief medical officer, said:“These data establishImfinzias the first immunotherapy to demonstrate an overall […]

Verastem Tackles FDA Approval For Blood Cancer Drug

Verastem Tackles FDA Approval For Blood Cancer Drug

Recently, Verastem (VSTM) announced that it had received FDA approval for its drug duvelisib to treat adult patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) as a third-line therapy. In addition, the FDA also gave COPIKTRA accelerated approval for patients with follicular lymphoma (FLL). This FDA approval will provide patients with an oral drug when […]

TG Therapeutics' credibility vanishes with blood cancer drug trial setback

TG Therapeutics' credibility vanishes with blood cancer drug trial setback

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days! SUBSCRIBE TODAY What is it? STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience. What’s included? Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy […]

AstraZeneca immunotherapy drug cuts lung cancer deaths by almost a third

AstraZeneca immunotherapy drug cuts lung cancer deaths by almost a third

LONDON (Reuters) – AstraZeneca’s immunotherapy drug Imfinzi cut the risk of death in patients with mid-stage lung cancer by nearly a third in a closely watched clinical study, reinforcing the case for using the drug in earlier disease. A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble […]

1 2 3 137